Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Guy R Heyndrickx
,
Gábor G Tóth
Added:
3 years ago
The presence as well as the extent of myocardial ischaemia are key to determining cardiovascular outcome,1–3 thus its identification is important. An endeavour to improve diagnostic accuracy in deciding which angiographic lesions are haemodynamically significant led to the development of the concept of fractional flow reserve (FFR). Based on pressure-flow analysis of a stenosis during maximum…
View more
Author(s):
Adrian P Banning
Added:
2 years ago
In this interview, Professor Adrian Banning (John Radcliffe Hospital, Oxford, UK) discusses the five-year outcomes of the SYNTAX II trial. This study aims to evaluate the impact of new technologies in percutaneous coronary intervention (PCI) by comparing the outcomes of these procedures to the original SYNTAX trial. The study showed that PCI moved forward considerably in the last 5 years, it is…
View more
Joost Lumens
Job title: Full Professor of Computational Cardiology at Maastricht University
Author
Start date:
Apr 14, 2021
End date:
Apr 16, 2021
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return for 2021 on April 14-16th, led by course director, Prof Nicolas van Mieghem from Erasmus MC, Rotterdam, NL.
TIO is a free virtual event that brings together…
View more
Author(s):
Johny Nicolas
,
Nicholas L Pitaro
,
Birgit Vogel
,
et al
Added:
11 months ago
Author(s):
Jacek Legutko
,
Joost Daemen
,
,
et al
Added:
1 year ago
Filmed at Transcatheter Interventions Online (TIO) on 15 – 17 March 2023, thisfascinating, educationalbreakout session is now available on demand.
ModeratorsProf Jacek Legutko (Jagiellonian University Medical College, John Paul II Hospital, Krakow, PL) andDr Joost Daemen (Erasmus University Medical Center, Rotterdam, NL) alongside a panel of experts discuss strategies on how to optimize…
View more
Author(s):
Frederik Zimmermann
Added:
1 year ago
In this late-breaking interview from ACC.22, Dr Frederik Zimmermann (Catharina Hospital, NL) outlines the main findings of the FAME 3 Trial.
FAME 3 is an international, randomised multicentre trial, that aims to compare the outcomes of fractional flow reserve (FFR)-guided PCI and Coronary Artery Bypass Graft Surgery (CABG) in patients with multivessel coronary artery disease. The results…
View more
Author(s):
Mark H Anderson
Added:
6 years ago